SkinBioTherapeutics PLC Holding(s) in Company (3057O)
31 January 2023 - 3:28AM
UK Regulatory
TIDMSBTX TIDMOPTI
RNS Number : 3057O
SkinBioTherapeutics PLC
30 January 2023
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying
issuer of existing shares to which voting SKINBIOTHERAPEUTICS PLC
rights are
attached ii :
---------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer(please mark with
an "X" if appropriate)
Non-UK issuer
------
2. Reason for the notification(please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
------
An acquisition or disposal of financial instruments
------
An event changing the breakdown of voting rights x
------
Other (please specify) iii :
------
3. Details of person subject to the notification obligation iv
Name Optibiotix Health Plc
---------------------------------------------------------
City and country of registered office UK
(if applicable)
---------------------------------------------------------
4. Full name of shareholder(s)(if different from 3.) v
Name
---------------------------------------------------------
City and country of registered office
(if applicable)
---------------------------------------------------------
5. Date on which the threshold was crossed 05/01/2023
or reached vi :
---------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 30/01/2023
---------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total number
at- tached to through financial Total of both of voting rights
shares (to- tal instru- ments in % (8.A + 8.B) of is- suer
of 8. A) (total of 8.B 1 vii
+ 8.B 2)
-------------------- ---------------------- ----------------------- --------------------
Resulting situation
on the date on
which
threshold was
crossed or reached 18.71% 173,138,854
-------------------- ---------------------- ----------------------- --------------------
Position of previous
notification (if
applicable) 20.67%
-------------------- ---------------------- ----------------------- --------------------
1
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of Number of voting rights ix % of voting rights
shares
ISIN code (if
possible)
------------------------------------------------------ --------------------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
----------------------- ----------------------------- ----------------------------- -------------------------
32,402,206 18.71%
----------------------- ----------------------------- ----------------------------- -------------------------
SUBTOTAL 8. A 32,402,206 18.71%
------------------------------------------------------ --------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Number of voting
Type of Expiration Exercise/ Conversion rights that may be % of voting
financial date x Period xi acquired if the instrument rights
in- strument is
exercised/converted.
------------ ------------------------------------ --------------------------------- -------------------------
SUBTOTAL 8. B 1
------------------------------------ --------------------------------- -------------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of
financial date x Conversion cash voting rights % of voting
instrument Pe- settlement rights
riod xi xii
----------------- ----------------------- ----------------------- --------------------- -------------------------
SUBTOTAL
8.B.2
----------------------- --------------------- -------------------------
9. Information in relation to the person subject to the notification obligation
(please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by X
any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer xiii
------
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity xiv
(please add additional rows as necessary)
------
% of voting rights % of voting rights Total of both if
if it equals or is through financial it equals or is higher
Name xv higher than the notifiable in- struments if than the notifiable
threshold it equals or is higher threshold
than the
notifiable threshold
------------------------------ --------------------------- ------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------------------
The number and % of voting rights held
-----------------------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------------------
11. Additional information xvi
Place of completion London
Date of completion 30/01/2023
-----------
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLBMMFTMTTJBAJ
(END) Dow Jones Newswires
January 30, 2023 11:28 ET (16:28 GMT)
OptiBiotix Health (AQSE:OPTI.GB)
Historical Stock Chart
From Oct 2024 to Nov 2024
OptiBiotix Health (AQSE:OPTI.GB)
Historical Stock Chart
From Nov 2023 to Nov 2024
